Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Further Success for Link Technologies in Asia

Published: Tuesday, February 26, 2013
Last Updated: Tuesday, February 26, 2013
Bookmark and Share
Japanese company GeneDesign joins growing list of distributors.

Following its announcement to expand into the Far East last month, certified specialist oligonucleotide reagent manufacturer Link Technologies Ltd, has agreed another distribution contract in Asia with Japanese company GeneDesign, Inc..

The deal comes just a few weeks after the signing of Zirench Technology for distribution in China.

Link Technologies is ISO 9001:2008 certified and manufacture a comprehensive range of reagents for DNA, RNA and PNA synthesis and modifications including a custom service for tailored compounds in specialist applications.

GeneDesign, located in Osaka, Japan, will represent Link Technologies throughout Japan and will be exhibiting at the forthcoming AsiaTIDES meeting on oligonucleotide and peptide research, technology and product development on February 26-28 in Tokyo, Japan.

Speaking about the agreement, Hideaki Sato, General Manager, Technical Support and Marketing at GeneDesign, Inc. said “Our collaboration with Link Technologies supports our goal of contributing to human welfare and health through nucleic acid technology development. We are delighted to be working with Link Technologies to increase the presence and usage of their high quality, reliable oligo precursor products in Japan. We invite people to visit us at the AsiaTIDES meeting to discover in detail the many benefits of these new offerings.”

Dr John Bremner, CEO at Link Technologies added “By working with GeneDesign we will be able to provide local access to our high quality products and offer our expert support services to customers throughout Japan. This level of accessibility is something we are very keen to continue to develop within Asia and worldwide, and forms part of our on-going strategic plans for development and growth. GeneDesign is a company that values the importance of this and we look forward to working with them.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

LINK Strengthens Presence in Switzerland
Link Technologies appoints Swiss company as first partner in Europe.
Tuesday, September 08, 2015
LINK Strengthens Presence in Switzerland with Distribution Agreement
Link Technologies appoints Swiss company Chemie Brunschwig AG as first partner in Europe.
Friday, September 04, 2015
LINK Strengthens Presence in Japan with New Distribution Agreements
Link Technologies appoints Cosmo Bio and Shigematsu to work alongside Gene Design.
Tuesday, June 30, 2015
LINK Strengthens Board with Appointment of Marc Lemaître
Lemaître to join Link Technologies Ltd. as non-executive Director.
Wednesday, February 25, 2015
New SAB Supports LINK’s Growing Range of Innovative Reagents
LINK creates SAB with Brian Sproat and Thomas Rupp as first two appointments.
Friday, January 16, 2015
LINK Appoints New CEO
LINK has appointed Dr David Ricketts as its new Chief Executive Officer.
Tuesday, September 30, 2014
Shining the Light on Oligonucleotide Labelling
Link Technologies’ new Product Guide is the ‘go-to’ resource for oligo chemistry.
Tuesday, July 23, 2013
Link Technologies Announces Expansion into the Far East with New Distributor
Zirench Technology signed as local distributor for the Chinese market.
Thursday, June 13, 2013
Link Technologies Announces Partnership with American International Chemical
AIC to distribute Link’s specialist oligonucleotide modifiers in North America.
Wednesday, May 23, 2012
Link Technologies Secures Exclusive License for Ultra Sensitive Diagnostic Probes
Deal marks the start of ongoing collaboration between Link and The University of Manchester.
Tuesday, December 01, 2009
Link Technologies Inks Exclusive License to Agilent Technologies’ TC RNA Monomers
Under the terms of the agreement Link will manufacture and sell the four RNA monomer phosphoramidite reagents for use in research.
Monday, May 18, 2009
PNA Monomers: A Licence to Deal
Link Technologies to manufacture and sell PNA Monomers following deal with PNA Inventor Group.
Friday, June 22, 2007
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos